West Pharmaceutical Services, Inc. to Acquire Medimop Medical Projects Ltd.
Medimop provides customers with technologies and systems for the reconstitution, transfer and administration of pharmaceutical products in therapeutic areas including multiple sclerosis, rheumatoid arthritis, vaccines, hormones and blood derivatives for haemophilia. Many drug products, including the majority of recently introduced biotechnology products, require reconstitution at the point of use because they are produced as freeze-dried powders in order to preserve product efficacy during shipment and storage.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.